Stocks
Arrowhead Pharmaceuticals (ARWR) Debt/EBITDA US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| Debt/EBITDA | 2.58 | 1.82 | 0.11 | -0.30 | -3.36 | 2.54 | ||
| Changes by years, y/y, % | -24% | -30% | -94% | -366% | +1 002% | |||
Arrowhead Pharmaceuticals. Debt/EBITDA
Arrowhead Pharmaceuticals. Debt/EBITDA, changes, %
Arrowhead Pharmaceuticals (ARWR) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | 2026Q2 | LTM ? | |||
| Debt/EBITDA | 5.24 | 3.56 | -3.36 | -1.63 | 2.54 | 2.54 | ||
| Changes by years, y/y, % | +1 766% | -10 477% | +1 002% | +197% | -52% | |||
| Changes by quarters, q/q, % | -1 053% | -32% | -194% | -51% | -255% | |||
